Phase II trial of topotecan as a 21-day continuous infusion in patients with advanced or metastatic adenocarcinoma of the pancreas
Stevenson, J.P, Scher, R.M, Kosierowski, R, Fox, S.C, Simmonds, M, Yao, K.-S, Green, F, Broom, C, Fields, S.Z, Krebs, J.B, O’Dwyer, P.J
Published in European journal of cancer (1990) (01.08.1998)
Published in European journal of cancer (1990) (01.08.1998)
Get full text
Journal Article